TY - BOOK ID - 113574226 TI - Targeting the Microbiome for Disease Diagnosis and Therapy : New Frontiers for Personalized Medicine PY - 2022 SN - 3036556117 3036556125 PB - Basel MDPI - Multidisciplinary Digital Publishing Institute DB - UniCat KW - Medicine KW - Graves–Basedow’s diseases KW - Hashimoto’s thyroiditis KW - autoimmunity KW - gut microbiota KW - irritable bowel syndrome KW - microbiota KW - microbiome KW - food components KW - nutrients KW - hematopoietic stem cell transplantation KW - fecal microbiota transplantation KW - aGvHD KW - antibiotic-resistant bacteria KW - cystic fibrosis KW - rabbits KW - intestinal dysbiosis KW - feces microbiome KW - beta-blocker KW - hemodialysis KW - next-generation sequencing KW - propensity score matching methods KW - violin plots KW - random sampling KW - analytical reproducibility KW - fecal matter transplantation KW - data disease subtypes KW - personalized medicine KW - maltodextrin KW - dip test KW - gallstone disease KW - 16S rDNA gene diversity KW - blood biochemical characteristics KW - mesothelioma KW - 16S RNA sequencing KW - species KW - probiotics and gut disease KW - probiotics and acute diverticulitis KW - probiotics and diverticular disease KW - probiotics mechanism of action KW - IgA Nephropathy KW - rifaximin KW - α1KI-CD89Tg mice KW - children KW - intermittent hypoxemia KW - obstructive sleep apnea KW - tonsil KW - weight status KW - oral microbiota KW - rheumatology diseases KW - biomarkers KW - artificial intelligence KW - machine learning KW - rheumatoid arthritis KW - Sjogren’s syndrome KW - systemic lupus erythematosus KW - endometrial cancer KW - endometrial microbiome KW - gut microbiome KW - dysbiosis KW - estrogen metabolism KW - estrobolome KW - inflammation KW - antitumour treatment KW - prebiotics KW - probiotics KW - schizophrenia KW - depression KW - anxiety KW - functional genes KW - thymoma KW - genera KW - driver mutation KW - cardiovascular diseases KW - critically ill KW - intestinal permeability KW - recurrent cystitis KW - n/a KW - Graves-Basedow's diseases KW - Hashimoto's thyroiditis KW - Sjogren's syndrome UR - https://www.unicat.be/uniCat?func=search&query=sysid:113574226 AB - Background: The gut microbiota is emerging as a pivotal player in the pathogenesis of many non-communicable diseases. Thus, it has been proposed as a new diagnostic and therapeutic target.Aim and scope: This Special Issue will focus on the microbiome as a potential target of new personalized therapies or diagnostic tools.History: In recent decades, the gut microbiome has been deeply investigated, and many studies have provided new information on the role of dysbiosis in many gastrointestinal and extra-gastrointestinal diseases. Recently, in addition to its phylogenetic characterization, new information has become available regarding the function of the gut microbiota, thanks to proteomic and metabolomic analyses.Cutting-edge research: The therapeutic modulation of the gut microbiota based on different strategies, including diet modification, antibiotics, prebiotics, probiotics, and, last but not least, fecal microbiota transplantation, has been tested for the treatment of various diseases. Recently, the possible applications and modalities of gut microbiota modulation have been increasingly expanding.We have collected original clinical or pre-clinical research papers and reviews focusing on the use of the microbiome for disease diagnosis, monitoring, or therapy and suggesting new possible gut microbiota-based approaches for personalized care. ER -